胎儿镜下气管封堵术治疗先天性膈疝:系统综述与荟萃分析
该系统综述与荟萃分析纳入20项研究共1187例先天性膈疝胎儿,评估胎儿镜下气管封堵术(FETO)与期待治疗的疗效。结果显示FETO可降低1个月和6个月死亡率,在重度CDH中还可降低肺动脉高压和ECMO使用率,但增加37周前早产和胎膜早破风险,不增加32周前早产等严重并发症。
要点
- FETO降低CDH胎儿1个月和6个月死亡率,重度CDH获益更明显。
- FETO增加37周前早产和胎膜早破风险,但不增加32周前早产。
- 重度CDH中FETO降低肺动脉高压和ECMO使用率,中度CDH无此效应。
核心结论
- FETO与CDH胎儿1个月和6个月死亡率降低相关,在重度CDH中还降低肺动脉高压率和ECMO使用率,但增加晚期早产风险而不导致极早产。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、EMBASE、Cochrane Library、CNKI、维普及万方数据库至2022年9月8日,纳入20项研究共1187例CDH胎儿,比较FETO与期待治疗,至少报告一项结局。
诊断标准与关键数值
- FETO组1个月死亡率OR 0.56(95%CI 0.34-0.93,P=0.02,NNT=7.67),6个月死亡率OR 0.34(95%CI 0.18-0.65,P=0.0009,NNT=5.26),证据质量中/低。
- FETO与37周前胎膜早破风险增加相关(OR 4.94,95%CI 2.25-10.88,P<0.0001,NNH=3.13),证据质量高/中。
- FETO与37周前早产风险增加相关(OR 5.24,95%CI 3.33-8.23,P<0.00001,NNH=2.79),证据质量高/中。
- 亚组分析显示FETO对肺动脉高压和ECMO使用率的影响在重度CDH中显著(证据质量低/中),在中度CDH中不显著(证据质量低/极低)。
- FETO与32周前早产、胎盘早剥或绒毛膜羊膜炎等严重并发症无显著关联(证据质量极低/低)。
临床应用与阅片要点
- 产前评估CDH胎儿时,可依据病情严重程度分层咨询FETO的获益与早产风险。
- 重度CDH胎儿行FETO可能降低肺动脉高压和ECMO需求,中度CDH仅见死亡率获益。
- 术后监测应关注37周前早产和胎膜早破,但32周前极早产风险未见显著增加。
局限性
- 纳入研究证据质量多为中至极低,部分结局的合并效应值需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: It is debated whether fetal endoscopic tracheal occlusion (FETO) is beneficial to fetuses with congenital diaphragmatic hernia (CDH) and whether FETO has different effects in moderate and severe CDH. We conducted a systematic review and meta-analysis including the latest evidence to assess the overall effects of FETO on clinical outcomes of CDH.
METHODS: We searched PubMed, EMBASE, The Cochrane Library, China National Knowledge Infrastructure, China Science and Technology Journal Database and Wanfang Database to retrieve eligible studies published before 8 September 2022. No language or study design restrictions were applied. Studies were included if CDH fetuses underwent FETO surgery and were compared with a cohort that underwent expectant management, with at least one outcome reported. The primary outcomes were mortality at 1, 6 and 12 months after birth, rates of pulmonary hypertension, use of extracorporeal membrane oxygenation (ECMO) and prematurity. Meta-analysis was conducted to obtain pooled odds ratios (ORs) and mean differences. The quality of included studies and pooled evidence was also assessed.
RESULTS: A total of 1187 CDH fetuses from 20 studies were included in the quantitative synthesis. FETO significantly reduced 1-month (OR, 0.56 (95% CI, 0.34-0.93); P = 0.02, number needed to treat (NNT) = 7.67) and 6-month (OR, 0.34 (95% CI, 0.18-0.65); P = 0.0009, NNT = 5.26) CDH mortality (moderate/low quality of evidence). Subgroup analysis suggested that the effects of FETO on the rates of pulmonary hypertension and ECMO usage were significant in severe CDH (low/moderate quality of evidence) but not in moderate CDH (low/very low quality of evidence). FETO was also associated with an increased risk of preterm prelabor rupture of membranes before 37 weeks' gestation (OR, 4.94 (95% CI, 2.25-10.88); P < 0.0001, number needed to harm (NNH) = 3.13) and preterm birth before 37 weeks (OR, 5.24 (95% CI, 3.33-8.23); P < 0.00001, NNH = 2.79) (high/moderate quality of evidence). However, FETO was not associated with severe complications, such as preterm birth before 32 weeks, placental abruption or chorioamnionitis (very low/low quality of evidence).
CONCLUSIONS: FETO is associated with a reduction in mortality, rate of pulmonary hypertension and ECMO usage in severe CDH, while it reduces only the risk of mortality in moderate CDH. Although FETO increases the risk of late prematurity, it does not result in extreme prematurity. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Chen, Xu, Xie, et al. Fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2023. PMID: 36704940. doi:10.1002/uog.26164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。